Inventor · disambiguated record
Carl-Magnus A. Andersson
Also filed as: ANDERSSON CARL-MAGNUS · ANDERSSON CARL-MAGNUS A · ANDERSSON CARL-MAGNUS ALEXANDE
32 granted patents·13 pending applications·863 citations·filing 1992–2021
98Inventor score
Files withACADIA PHARM INC28ASTRA AB6ANDERSSON CARL-MAGNUS A3ANDERSSON CARL-MAGNUS2THYGESEN MIKKEL B2
Top patents by PatentIndex Score
45 records- 0198US8921393B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 30, 2014·41 cites·36 claims
- 0297US10028944B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2017·Granted Jul 24, 2018·15 cites·15 claims
- 0397US9566271B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 0497US8377959B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2012·Granted Feb 19, 2013·26 cites·12 claims
- 0597US8008323B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 30, 2011·25 cites·9 claims
- 0697US7994193B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 9, 2011·29 cites·9 claims
- 0797US7732462B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Jun 8, 2010·36 cites·24 claims
- 0897US7659285B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Feb 9, 2010·33 cites·11 claims
- 0997US7601740B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·26 claims
- 1096US10525046B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2018·Granted Jan 7, 2020·12 cites·20 claims
- 1196US9211289B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2014·Granted Dec 15, 2015·20 cites·13 claims
- 1296US7713995B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted May 11, 2010·30 cites·15 claims
- 1396US6815458B2Azacyclic compoundsACADIA PHARM INC·Filed 2001·Granted Nov 9, 2004·85 cites·48 claims
- 1496US6756393B2Azacyclic compoundsACADIA PHARM INC·Filed 2003·Granted Jun 29, 2004·77 cites·5 claims
- 1595US9296694B2Azacyclic compoundsACADIA PHARM INC·Filed 2015·Granted Mar 29, 2016·17 cites·4 claims
- 1695US8618130B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 31, 2013·25 cites·15 claims
- 1794US8227487B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesWEINER DAVID M·Filed 2011·Granted Jul 24, 2012·25 cites·12 claims
- 1894US7923564B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2010·Granted Apr 12, 2011·26 cites·6 claims
- 1994US7732615B2N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2005·Granted Jun 8, 2010·29 cites·24 claims
- 2093US7538222B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2005·Granted May 26, 2009·19 cites·24 claims
- 2191US8236960B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsTHYGESEN MIKKEL BOAS·Filed 2011·Granted Aug 7, 2012·20 cites·10 claims
- 2291US7476682B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2006·Granted Jan 13, 2009·23 cites·50 claims
- 2390US7253186B2N-substituted piperidine derivatives as serotonin receptor agentsANDERSSON CARL-MAGNUS·Filed 2003·Granted Aug 7, 2007·46 cites·33 claims
- 2488US9765053B2Methods of treatment using selective 5-HT2A inverse agonistsANDERSSON CARL-MAGNUS A·Filed 2011·Granted Sep 19, 2017·12 cites·5 claims
- 2586US6627645B2Muscarinic agonistsACADIA PHARM INC·Filed 2001·Granted Sep 30, 2003·25 cites·65 claims
- 2685US5385904AOrganic salts of N,N'-diacetyl cystineASTRA AB·Filed 1992·Granted Jan 31, 1995·60 cites·6 claims
- 2781US2022241265A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2879US2024091212A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2978US2020323836A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2019·Application pending·0 cites
- 3068US2009186921A1Azacyclic compoundsACADIA PHARM INC·Filed 2009·Application pending·0 cites
- 3161US2016237036A1Azacyclic compoundsACADIA PHARM INC·Filed 2016·Application pending·0 cites
- 3260US5441976APharmacological use of certain cystine derivativesASTRA AB·Filed 1992·Granted Aug 15, 1995·13 cites·14 claims
- 3360US2006205780A1Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsTHYGESEN MIKKEL B·Filed 2006·Application pending·0 cites
- 3460US2006205781A1Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsTHYGESEN MIKKEL B·Filed 2006·Application pending·0 cites
- 3559US2005014757A1Azacyclic compoundsFiled 2004·Application pending·0 cites
- 3658US2006194778A1Azacyclic compoundsANDERSSON CARL-MAGNUS A·Filed 2006·Application pending·0 cites
- 3758US2006194834A1Azacyclic compoundsANDERSSON CARL-MAGNUS A·Filed 2006·Application pending·0 cites
- 3856US2007155795A1Muscarinic agonistsACADIA PHARM INC·Filed 2007·Application pending·0 cites
- 3950US5804582AMethod for the treatment of diseases due to defects the immune systemASTRA AB·Filed 1995·Granted Sep 8, 1998·6 cites·3 claims
- 4049US2004077529A1Urotensin II receptor agentsFiled 2003·Application pending·0 cites
- 4147US5780508APharmacological preparations comprising a cystine derivativeASTRA AB·Filed 1995·Granted Jul 14, 1998·6 cites·2 claims
- 4244US2011014243A1Pharmaceutical compositionsANDERSSON CARL-MAGNUS·Filed 2008·Application pending·0 cites
- 4341US5824681AOrganic salts of N,N'-diacetyl cystineASTRA AB·Filed 1995·Granted Oct 20, 1998·1 cites·5 claims
- 4436US6951958B1Solid phase parallel synthesis of tertiary aminesACADIA PHARM INC·Filed 2000·Granted Oct 4, 2005·0 cites·34 claims
- 4533US5889050A3,3'-dithiobis (propionic acids) and esters thereofASTRA AB·Filed 1994·Granted Mar 30, 1999·4 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Carl-Magnus A. Andersson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →